Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 115.4B | 134.9B | 130.7B |
Cost of revenue | — | 47.1B | 53.8B | 52.9B |
Gross profit | — | 68.3B | 81.1B | 77.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 7.5B | 20.6B | 18.3B |
Non operating interest income | ||||
Income | — | 3.3B | 3.1B | 2.7B |
Expense | — | 175M | 165M | 168M |
Other income expense | — | — | — | — |
Pretax income | — | 11.5B | 26.7B | 21.3B |
Tax provision | — | 2.1B | 7.0B | 7.0B |
Net income | — | 9.4B | 19.6B | 14.3B |
Basic EPS | 46.5 | — | — | — |
Diluted EPS | 46.5 | — | — | — |
Basic average shares | 303.1M | — | — | — |
Diluted average shares | 303.1M | — | — | — |
EBITDA | — | 10.5B | 26.9B | 21.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -1.7B | -2.3B | -1.4B |
Preferred stock dividends | — | 0 | 0 | 0 |